ANTIKOAGULYANTLAR VA ANTIAGREGANTLARNING KLINIK QO‘LLANILISHI: ZAMONAVIY YONDASHUVLAR VA SAMARADORLIK

Authors

  • Usmonov Shoxjaxon Bozirgon o‘g‘li, Farxodov Og‘abek Bobomurodovich Qorako‘l Abu Ali ibn Sino nomidagi Jamoat salomatligi texnikumi.

Abstract

Mazkur maqolada antikoagulyant va antiagregant dori vositalarining ta’sir mexanizmi, klinik qo‘llanilishi, samaradorligi hamda xavfsizlik jihatlari tahlil qilinadi. Ushbu preparatlar tromboz va tromboemboliyani oldini olishda muhim ahamiyatga ega bo‘lib, yurak-qon tomir kasalliklarida keng qo‘llaniladi.

References

1. World Health Organization. Cardiovascular Diseases Report, 2021

2. ESC Guidelines. Anticoagulation Therapy, 2020

3. ACC/AHA Guidelines. Management of Thrombosis, 2019

4. Goodman & Gilman. Pharmacology, 2018

5. Katzung BG. Basic & Clinical Pharmacology, 2021

6. Hirsh J. Heparin Mechanism, Blood Journal

7. Connolly SJ. DOAC Trials, NEJM

8. Patrono C. Aspirin in Cardiovascular Disease, Lancet

9. Mega JL. Antiplatelet Therapy, Circulation

10. Weitz JI. Anticoagulants Overview, 2020

Downloads

Published

2026-03-27

Issue

Vol. 3 No. 3 (2026): Introduction of new innovative technologies in education of pedagogy and psychology

Section

Articles